RSS

antibiotics

Polyphor — a clinical stage Swiss biopharmaceutical company — has raised CHF 6.8 million from the Novo REPAIR Impact Fund to accelerate the development of novel antibiotics against multi-drug resistant Gram-negative pathogens. more

News

Biotechnology company, Phico Therapeutics, has been awarded significant funding from Innovate UK to support the manufacturing development of its intravenous antibiotic, SASPject PT3.8. more

News

As the UK enjoys a prolonged period of hot and sunny weather, a threat is becoming apparent in the form of serious infection due to horsefly bites, according to the charity, Antibiotic Research UK (ANTRUK). more

News

A European research, development and innovation organisation, VTT Technical Research Centre of Finland, has developed a vaccine for piglets to reduce the use of antibiotics and help with the global issue of antimicrobial resistance (AMR). more

News

Yesterday (Tuesday 26 June) saw the Liverpool Business Festival play host to the Health and Life Sciences sector and featured a selection of presentations from key opinion leaders, including Lord Jim O’Neill. more

News

Biopharmaceutical company, Oppilotech, has been awarded with a grant from Innovate UK to expand its computational model of the outer wall of Gram-negative bacteria. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

A study has been published looking at the mechanism of action of odilorhabdins — a new class of antibiotics — to combat antibiotic resistance, disclosed Nosopharm and the University of Illinois at Chicago (UIC) more

News

Swiss-based specialty pharma company, Polyphor, has announced that the first patient has been enrolled in the Phase III clinical trial for murepavadin — a pathogen-specific antibiotic being developed for the treatment of nosocomial pneumonia more

News

A biotech company, Deinove, has signed an exclusive research licence with Italian biopharma company, Naicons, to aid in the discovery of new antibiotics through the Antibiotics against Resistant Infectious Germs (AGIR) project. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Recent research from a team at Rockefeller University has uncovered natural compounds in soil samples that may be useful in the treatment of several bacterial infections that have become resistant to multiple antibiotics. more

News

Debiopharm Group, international biopharmaceutical group, has continued its efforts in the fight against antibiotic resistance by investing in antibiotic development through acquiring a minority stake in ABAC Therapeutics. more

News

A company dedicated to the research and development of new anti-infective drugs, Nosopharm, has received funding from Bpifrance worth €1 million in the form of an interest-free loan. more

News

Steps are being taken by pharma to openly share data on changes to the susceptibility of pathogens to antibiotics around the world as part of a pilot project to tackle the growing problem of drug-resistant infections. more

News

The Access to Medicine Foundation has published an independent analysis of the efforts made by pharma companies to address the issue of drug resistant infections. more

Analysis

In this case study, BHS-Sonthofen looks at how production process redesign, implementing a rotary pressure filter, can improve yield. more

Opinion

The AMR Centre (AMRC) and EligoChem have entered into an agreement for the co-development of antimicrobial peptides to treat drug-resistant Gram-negative bacteria, such as E. coli. more

News

Speaking at the launch of the AMR Centre in Alderley Park, Cheshire, two experts in the field of antimicrobial resistance (AMR) have raised concerns that research into this serious public health threat are lagging and a ‘renewed focus’ is essential. more

News

Two new research polls, commissioned by The Longitude Prize, have demonstrated that even though there has been a reduction in the number of prescribed antibiotics GPs are still inclined to err on the side of caution. more

Analysis